Viewing Study NCT03292302


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-01-10 @ 12:36 AM
Study NCT ID: NCT03292302
Status: COMPLETED
Last Update Posted: 2023-08-22
First Post: 2017-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of ELX-02 in Healthy Adults
Sponsor: Eloxx Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module